MicroRNA‑433 reduces cell proliferation and invasion in non‑small cell lung cancer via directly targeting E2F transcription factor 3

Molecular Medicine Reports
Nian LiuXiuying Li

Abstract

MicroRNAs (miRNA/miRs) have been associated with the initiation and progression of non‑small‑cell lung cancer (NSCLC). Hence, a comprehensive understanding of the association between dysregulated miRNAs and NSCLC may contribute to the identification of novel therapeutic methods for patients with NSCLC. MiRNA‑433 (miR‑433) has been reported to be dysregulated in numerous types of human cancers; however, its expression pattern, biological roles and associated mechanisms in NSCLC require further investigation. The present study aimed to detect miR‑433 expression and determine its roles and underlying molecular mechanisms in NSCLC. In the present study, reverse transcription‑quantitative polymerase chain reaction revealed that miR‑433 was significantly downregulated in NSCLC tissues and cell lines. This decreased miR‑433 expression was strongly associated with the tumor node metastasis stage and lymph node metastasis of patients with NSCLC. Cell Counting kit‑8 and cell invasion assays revealed that the resumption of miR‑433 expression decreased the proliferation and invasion of NSCLC cells. Bioinformatics analysis predicted E2F transcription factor 3 (E2F3) as a potential target of miR‑433. Luciferase reporter assay, RT‑qPCR and we...Continue Reading

References

Feb 16, 2002·Methods : a Companion to Methods in Enzymology·K J Livak, T D Schmittgen
Feb 8, 2006·Proceedings of the National Academy of Sciences of the United States of America·Stefano VoliniaCarlo M Croce
Aug 4, 2006·Cancer Research·George Adrian Calin, Carlo Maria Croce
Aug 30, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Colin S CooperShu-Jun Cheng
Jun 4, 2008·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yoichi NaitoYutaka Nishiwaki
Dec 18, 2009·Journal of Cellular and Molecular Medicine·Luis Paz-AresBarbara Klughammer
Dec 23, 2009·The International Journal of Biochemistry & Cell Biology·William C S Cho
Jul 9, 2010·CA: a Cancer Journal for Clinicians·Ahmedin JemalElizabeth Ward
Jun 18, 2011·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·María Cortés-Sempere, Inmaculada Ibáñez de Cáceres
May 10, 2013·Annual Review of Biophysics·Ross C Wilson, Jennifer A Doudna
Jul 25, 2013·International Journal of Molecular Sciences·Li-Hua GuoJin-Sheng He
Jun 5, 2014·Journal of Translational Medicine·Xuelian LiBaosen Zhou
Feb 6, 2015·CA: a Cancer Journal for Clinicians·Lindsey A TorreAhmedin Jemal
Nov 10, 2015·Oncogene·P TrikhaG Leone
Dec 4, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Dong DongGuishan Gu
Jul 30, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Xiaohua LiRui Wang
Dec 7, 2016·International Journal of Oncology·Jiang-Ping WangBo Zhang
Mar 9, 2017·Cancer Biomarkers : Section a of Disease Markers·Hala Abdel Al Ahmed, Ola Nada
May 11, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Xiaojian ZhaoJiabao Liu
Jun 8, 2017·Oncology Letters·Yong GuoXiaoyong Chu
Nov 9, 2017·Oncotarget·Diana CastroRamon Andrade De Mello
Dec 5, 2017·Critical Reviews in Oncology/hematology·Bhavesh K AhirSajani S Lakka
Feb 1, 2018·Oncotarget·Irina FadejevaAndelko Hrzenjak

❮ Previous
Next ❯

Citations

Mar 1, 2019·Cancers·Shang-Gin WuJin-Yuan Shih

❮ Previous
Next ❯

Related Concepts